For: | Auguste PE, Mistry H, McCarthy ND, Sutcliffe PA, Clarke AE. Cost-effectiveness of testing for latent tuberculosis infection in people with HIV. AIDS 2022;36:1-9. [PMID: 34873091 DOI: 10.1097/QAD.0000000000003060] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis] |
---|
Number | Citing Articles |
1 | Fekadu G, Yao J, You JHS. Cost effectiveness analysis of single and sequential testing strategies for tuberculosis infection in adults living with HIV in the United States. Sci Rep 2022;12:18349. [PMID: 36319676 DOI: 10.1038/s41598-022-22721-z] [Reference Citation Analysis] |
2 | Yang Y, Wang H, Hu W, Bai G, Hua C. Diagnostic Value of Interferon-Gamma Release Assays for Tuberculosis in the Immunocompromised Population. Diagnostics 2022;12:453. [DOI: 10.3390/diagnostics12020453] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis] |